Steven W. Spector
2014
Compensation breakdown
Non-Equity Incentive Plan | $163,925 |
---|---|
Option Awards | $191,490 |
Salary | $415,000 |
Stock Awards | $1,059,600 |
Other | $16,320 |
Total | $1,846,335 |
Spector received $1.1M in stock awards, accounting for 57% of the total pay in 2014.
Spector also received $163.9K in non-equity incentive plan, $191.5K in option awards, $415K in salary and $16.3K in other compensation.
Rankings
In 2014, Steven W. Spector's compensation ranked 4,846th out of 13,032 executives tracked by ExecPay. In other words, Spector earned more than 62.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,846 | 63rd |
Manufacturing | 1,732 | 65th |
Chemicals And Allied Products | 567 | 66th |
Drugs | 433 | 68th |
Pharmaceutical Preparations | 345 | 67th |
Spector's colleagues
We found six more compensation records of executives who worked with Steven W. Spector at Arena Pharmaceuticals in 2014.
2014
Jack Lief
Arena Pharmaceuticals
Chief Executive Officer
2014
Dominic Behan
Arena Pharmaceuticals
Chief Scientific Officer
2014
William Shanahan
Arena Pharmaceuticals
Chief Medical Officer
2014
Robert Hoffman
Arena Pharmaceuticals
Chief Financial Officer
2014
Craig Audet
Arena Pharmaceuticals
Former Senior Vice President, Operations and Head of Global Regulatory Affairs
2014
Harry Hixson
Arena Pharmaceuticals